Profile
ABVC VRTX REGN ALNY SGEN ARGX
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $45.85M $117.98B $59.32B $43.28B $43.15B $40.50B
Employees 0.02K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Uttam Yashwant Patil Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABVC VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 4
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Buy
Trading
ABVC VRTX REGN ALNY SGEN ARGX
Last Close $2.7 $366.54 $563 $438.93 $228.74 $661.83
High 52 $4.76 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $0.41 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -43.28 % -29.07 % -53.15 % 0 % 0 % -4.13 %
Price vs. 52 Week Low 558.54 % 0 % 16.58 % 95.44 % 0 % 28.7 %
Total Return
ABVC VRTX REGN ALNY SGEN ARGX
1 Month Return -42.31 % -23.47 % 1.9 % 36.86 % 0 % 19.21 %
3 Month Return 123.14 % -13.75 % 6.67 % 74.77 % 0 % 20.41 %
6 Month Return 542.86 % -21.9 % -20.65 % 58.92 % 0 % 2.35 %
9 Month Return 412.82 % -29.07 % -32.04 % 58.21 % 0 % 11.05 %
YTD Return 357.63 % -8.98 % -20.96 % 86.53 % 0 % 7.61 %
1 Year Return 291.87 % -21.75 % -50.23 % 62.86 % 0 % 23.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
ABVC VRTX REGN ALNY SGEN ARGX
Asset Growth -47.97 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth 439.6 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth 233.81 % 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year -71.12 % 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year -89.77 % 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year 6.53 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth 44.32 % -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth 53.38 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share 91.77 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share 82.42 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share -6.84 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth 42.73 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) 57.29 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG 95.19 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG 91.86 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG -478.77 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth 82.3 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth 82.3 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share -96.89 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -97.2 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 214.57 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -70.34 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth 6.7 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth 57.5 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ABVC VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 99.9 % 86.03 % 87.44 % 86.01 % 79.1 % 65.32 %
Return on Assets TTM -12.18 % -4.32 % 11.67 % -6.4 % -16.61 % 15.06 %
Return on Equity TTM -31.14 % -6.25 % 14.43 % -509.33 % -20.8 % 18.96 %
Return on Capital Employed TTM -23.84 % -3.89 % 11.12 % -3.68 % -21.46 % 5.04 %
Net Income Per EBT TTM 77.68 % 329.41 % 91.46 % 75.89 % 101.33 % 237.3 %
EBT Per Ebit TTM 119.39 % 40.44 % 126.92 % 308.03 % 98.26 % 147.38 %
EBIT Per Revenue TTM -384.37 % -6.69 % 27.02 % -4.91 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -75.09 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Receivables Turnover TTM 0.95 6.15 2.53 5.62 3.91 1.91
Payables Turnover TTM - 3.49 2.47 3.37 1.97 0.88
Inventory Turnover TTM 0.04 1.14 0.56 5.01 0.96 2.21
Fixed Asset Turnover TTM 5.41 % 421.34 % 293.64 % 337.41 % 665.41 % 5009.77 %
Asset Turnover TTM 3.42 % 48.51 % 37.19 % 55.72 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -0.11 -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.13 -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 1.45 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -320.56 % -8.83 % 33.37 % -1.92 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 115.1 % 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -75.09 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -24.44 -93.78 15.43 -574.08 -81.26 -521.84
Price To Operating Cash Flows Ratio TTM -24.8 -120.39 12.38 -954.11 -93.1 -618.62
Price Cash Flow Ratio TTM -24.8 -120.39 12.38 -954.11 -93.1 -618.62
Income Statement (TTM)
ABVC VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 99.85% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.43 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABVC VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
ABVC VRTX REGN ALNY SGEN ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.95
AARD Aardvark Therapeutics, Inc. Common Stock 11.99
ABCL AbCellera Biologics Inc. 4.25
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.26
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0368
ABSI Absci Corporation 2.84
ABUS Arbutus Biopharma Corporation 3.4
ABVX Abivax SA American Depositary Shares 70.13
ACAD ACADIA Pharmaceuticals Inc. 24.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.621
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.5
ACIU AC Immune SA 2.14
ACLX Arcellx, Inc. 70.5
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 313.03
VXF Vanguard Extended Market Index Fund 0.00022 196.6
IWC iShares Micro-Cap ETF 0 131.82
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00022 149.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00022 149.15
VEMPX Vanguard Extended Market Index InstlPlus 0.00022 368.04
Unlock